|
1
|
Gharani N, Keller MA, Stack CB, Hodges LM, Schmidlen TJ, Lynch DE, Gordon ES, Christman MF. The Coriell personalized medicine collaborative pharmacogenomics appraisal, evidence scoring and interpretation system. Genome Med 2013; 5:93. [PMID: 24134832 PMCID: PMC3978656 DOI: 10.1186/gm499] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2013] [Accepted: 09/16/2013] [Indexed: 12/15/2022] Open
Abstract
Implementation of pharmacogenomics (PGx) in clinical care can lead to improved drug efficacy and reduced adverse drug reactions. However, there has been a lag in adoption of PGx tests in clinical practice. This is due in part to a paucity of rigorous systems for translating published clinical and scientific data into standardized diagnostic tests with clear therapeutic recommendations. Here we describe the Pharmacogenomics Appraisal, Evidence Scoring and Interpretation System (PhAESIS), developed as part of the Coriell Personalized Medicine Collaborative research study, and its application to seven commonly prescribed drugs.
Collapse
Affiliation(s)
- Neda Gharani
- The Coriell Institute for Medical Research, 403 Haddon Avenue, Camden, NJ 08103, USA
| | - Margaret A Keller
- The Coriell Institute for Medical Research, 403 Haddon Avenue, Camden, NJ 08103, USA ; Current Address: American Red Cross, 700 Spring Garden Street, Philadelphia, PA 19123, USA
| | - Catharine B Stack
- The Coriell Institute for Medical Research, 403 Haddon Avenue, Camden, NJ 08103, USA ; Current Address: Annals of Internal Medicine, 190 N. Independence Mall West, Philadelphia, PA 19106, USA
| | - Laura M Hodges
- The Coriell Institute for Medical Research, 403 Haddon Avenue, Camden, NJ 08103, USA
| | - Tara J Schmidlen
- The Coriell Institute for Medical Research, 403 Haddon Avenue, Camden, NJ 08103, USA
| | - Daniel E Lynch
- The Coriell Institute for Medical Research, 403 Haddon Avenue, Camden, NJ 08103, USA
| | - Erynn S Gordon
- The Coriell Institute for Medical Research, 403 Haddon Avenue, Camden, NJ 08103, USA
| | - Michael F Christman
- The Coriell Institute for Medical Research, 403 Haddon Avenue, Camden, NJ 08103, USA
| |
Collapse
|
|
2
|
Margaret A Keller, Erynn S Gordon, Catharine B Stack, Neda G. Coriell Personalized Medicine Collaborative®: a prospective study of the utility of personalized medicine. Per Med 2010; 7:301-317. [DOI: 10.2217/pme.10.13] [Citation(s) in RCA: 50] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
There is a dearth of large prospective studies to determine if genetic risk factors are useful predictors of health outcomes and if reporting them to individuals or physicians changes health behavior. The Coriell Personalized Medicine Collaborative® (CPMC, NJ, USA) is a prospective observational study with three cohorts – community, cancer and chronic disease cohorts. Participants provide detailed medical history through a dynamic internet-based portal. DNA is tested and personalized risk reports are provided for potentially actionable health conditions. To date, the community cohort has enrolled 4372 participants. The internet-based portal supplies educational content, captures phenotypic data and delivers customized risk reports. The Informed Cohort Oversight Board has approved 16 health conditions to date, and risk reports with genetic and nongenetic risks for six conditions have been released. The majority (87%) of participants who completed requisite questionnaires viewed at least one report. The CPMC is a cohort study delivering customized risk reports for actionable conditions using a web interface and measuring outcomes longitudinally.
Collapse
|